Basic Information
| RNALocate ID: | RLID:11001628 |
| RNA Symbol: | hsa-let-7g-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-let-7g |
| RNA ID: | miRBase:MIMAT0000414 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23056502 |
| Tissue/Cell Line: | Epidermal melanocytes (HEMa-LP)|Malignant melanoma cell line (A375) |
| Method: | Microarray |
| Description: | To distinguish miRNA signatures between melanoma cell-derived exosomes and normal melanocyte-derived exosomes, we compared the miRNome in A375 and HEMa-LP exosomes. We identified 130 miRNAs upregulated and 98 miRNAs downregulated in A375 versus HEMa-LP exosomes (Table S6). Data are collected from table S6. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001694 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001695 | Cytoplasm | HeLa cells | 22058130 |
| RLID:01001696 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001697 | Mitochondrion | HEK-293 cells|HeLa cells|Myotube | 27396686 |
| RLID:01001698 | Mitochondrion | HEK-293 cells|HeLa cells|Skeletal muscle cells | 27563705 |
| RLID:01001699 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001700 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001701 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001702 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001703 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001704 | Nucleus | HeLa cells | 22058130 |
| RLID:11001622 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
| RLID:11001623 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
| RLID:11001624 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001625 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001626 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001627 | Exosome | Breast milk | 22211110 |
| RLID:11001629 | Exosome | Saliva | 23302638 |
| RLID:11001630 | Exosome | Brain tissue | 23382797 |
| RLID:11001631 | Exosome | Plasma | 23663360 |
| RLID:11001632 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
| RLID:11001633 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001634 | Microvesicle | Plasma | 19002258 |
| RLID:11001635 | Microvesicle | Plasma | 23077538 |
| RLID:11001636 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001637 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11001638 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000068 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000342 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-let-7g-5p | Diffuse large b cell lymphoma | MNDR-E-MI-01982 |
| MNDR | hsa-let-7g-5p | Splenic marginal zone lymphoma | MNDR-E-MI-01983 |
| MNDR | hsa-let-7g-5p | Oral squamous cell carcinoma | MNDR-E-MI-01984 |
| MNDR | hsa-let-7g-5p | B cell lymphoma of malt type | MNDR-E-MI-01985 |
| MNDR | hsa-let-7g-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-01986 |
| MNDR | hsa-let-7g-5p | Lymphoma | MNDR-E-MI-01987 |
| MNDR | hsa-let-7g-5p | Lymphoma non-hodgkin | MNDR-E-MI-01988 |
| MNDR | hsa-let-7g-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-01989 |
| MNDR | hsa-let-7g-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-01990 |
| MNDR | hsa-let-7g-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-01991 |
| MNDR | hsa-let-7g-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-01992 |
| MNDR | hsa-let-7g-5p | Breast cancer luminal | MNDR-E-MI-01993 |
| MNDR | hsa-let-7g-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-01994 |
| MNDR | hsa-let-7g-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-01995 |
| MNDR | hsa-let-7g-5p | Prostate cancer | MNDR-E-MI-01996 |
| MNDR | hsa-let-7g-5p | Gastric cancer | MNDR-E-MI-01997 |
| MNDR | hsa-let-7g-5p | Gastric lymphoma | MNDR-E-MI-01998 |
| MNDR | hsa-let-7g-5p | Alzheimer disease | MNDR-E-MI-01999 |
| MNDR | hsa-let-7g-5p | Dysautonomia familial | MNDR-E-MI-02000 |
| MNDR | hsa-let-7g-5p | Head and neck cancer | MNDR-E-MI-02001 |
| MNDR | hsa-let-7g-5p | Malaria | MNDR-E-MI-02002 |
| MNDR | hsa-let-7g-5p | Leukemia | MNDR-E-MI-02003 |
| MNDR | hsa-let-7g-5p | Cardiovascular disease | MNDR-E-MI-02004 |
| MNDR | hsa-let-7g-5p | Lung cancer | MNDR-E-MI-02005 |
| MNDR | hsa-let-7g-5p | Metabolic syndrome x | MNDR-E-MI-02006 |
| MNDR | hsa-let-7g-5p | Parkinson disease | MNDR-E-MI-02007 |
| MNDR | hsa-let-7g-5p | Breast cancer | MNDR-E-MI-02008 |
| MNDR | hsa-let-7g-5p | Thyroid cancer | MNDR-E-MI-02009 |
| MNDR | hsa-let-7g-5p | Pancreatic cancer | MNDR-E-MI-02010 |
| MNDR | hsa-let-7g-5p | Melanoma | MNDR-E-MI-02011 |
| MNDR | hsa-let-7g-5p | Rectum adenocarcinoma | MNDR-E-MI-02012 |
| MNDR | hsa-let-7g-5p | Nephroblastoma | MNDR-E-MI-02013 |
| MNDR | hsa-let-7g-5p | Colon cancer | MNDR-E-MI-02014 |
| MNDR | hsa-let-7g-5p | Ischemic attack transient | MNDR-E-MI-02015 |
| MNDR | hsa-let-7g-5p | Colon adenocarcinoma | MNDR-E-MI-02016 |
| MNDR | hsa-let-7g-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-02017 |
| MNDR | hsa-let-7g-5p | Familial ovarian cancer | MNDR-E-MI-02018 |
| MNDR | hsa-let-7g-5p | Prostate adenocarcinoma | MNDR-E-MI-02019 |
| MNDR | hsa-let-7g-5p | Carcinoma ductal breast | MNDR-E-MI-02020 |
| MNDR | hsa-let-7g-5p | Glioblastoma | MNDR-E-MI-02021 |
| MNDR | hsa-let-7g-5p | Malignant glioma | MNDR-E-MI-02022 |
| MNDR | hsa-let-7g-5p | Chordoma | MNDR-E-MI-02023 |
| MNDR | hsa-let-7g-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-02024 |
| MNDR | hsa-let-7g-5p | Liposarcoma | MNDR-E-MI-02025 |
| MNDR | hsa-let-7g-5p | Liver cancer | MNDR-E-MI-02026 |
| MNDR | hsa-let-7g-5p | Uterine cancer | MNDR-E-MI-02027 |
| MNDR | hsa-let-7g-5p | Cervical adenocarcinoma | MNDR-E-MI-02028 |
| MNDR | hsa-let-7g-5p | Gastric adenocarcinoma | MNDR-E-MI-02029 |
| MNDR | hsa-let-7g-5p | Non-small cell lung cancer | MNDR-E-MI-02030 |
| MNDR | hsa-let-7g-5p | Lung adenocarcinoma | MNDR-E-MI-02031 |
| MNDR | hsa-let-7g-5p | Adrenocortical cancer | MNDR-E-MI-02032 |
| MNDR | hsa-let-7g-5p | Thyroid carcinoma | MNDR-E-MI-02033 |
| MNDR | hsa-let-7g-5p | Tuberculosis | MNDR-E-MI-02034 |
| MNDR | hsa-let-7g-5p | Carcinoma renal cell | MNDR-E-MI-02035 |
| MNDR | hsa-let-7g-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-02036 |
| MNDR | hsa-let-7g-5p | Clear cell renal cell carcinoma | MNDR-E-MI-02037 |
| MNDR | hsa-let-7g-5p | Biliary tract cancer | MNDR-E-MI-02038 |
| MNDR | hsa-let-7g-5p | Cholangiocarcinoma | MNDR-E-MI-02039 |
| MNDR | hsa-let-7g-5p | Esophageal cancer | MNDR-E-MI-02040 |
| MNDR | hsa-let-7g-5p | Liver cirrhosis | MNDR-E-MI-02041 |
| MNDR | hsa-let-7g-5p | Testicular germ cell cancer | MNDR-E-MI-02042 |
| MNDR | hsa-let-7g-5p | T acute lymphoblastic leukemia | MNDR-E-MI-02043 |
| MNDR | hsa-let-7g-5p | Acute t cell leukemia | MNDR-E-MI-02044 |
| MNDR | hsa-let-7g-5p | Breast invasive carcinoma | MNDR-E-MI-02045 |
| MNDR | hsa-let-7g-5p | Early hepatocellular carcinoma | MNDR-E-MI-02046 |
| MNDR | hsa-let-7g-5p | Familiar ovarian carcinoma | MNDR-E-MI-02047 |
| MNDR | hsa-let-7g-5p | B-cell lymphoma | MNDR-E-MI-02048 |
| MNDR | hsa-let-7g-5p | Rheumatoid arthritis | MNDR-E-MI-02049 |
| MNDR | hsa-let-7g-5p | T-cell leukemia | MNDR-E-MI-02050 |
| MNDR | hsa-let-7g-5p | Neuroblastoma | MNDR-E-MI-02051 |
| MNDR | hsa-let-7g-5p | Hodgkin lymphoma | MNDR-E-MI-02052 |
| MNDR | hsa-let-7g-5p | Burkitt lymphoma | MNDR-E-MI-02053 |
| MNDR | hsa-let-7g-5p | Neurological disease | MNDR-E-MI-02054 |
| MNDR | hsa-let-7g-5p | Crohn disease | MNDR-E-MI-02055 |
| MNDR | hsa-let-7g-5p | Neuromyelitis optica | MNDR-E-MI-02056 |
| MNDR | hsa-let-7g-5p | Acute myelogenous leukemia | MNDR-E-MI-02057 |
| MNDR | hsa-let-7g-5p | Colorectal cancer | MNDR-E-MI-02058 |
| MNDR | hsa-let-7g-5p | Nasopharynx carcinoma | MNDR-E-MI-02059 |
| MNDR | hsa-let-7g-5p | Multiple myeloma | MNDR-E-MI-02060 |
| MNDR | hsa-let-7g-5p | Nasopharyngeal cancer | MNDR-E-MI-02061 |
| MNDR | hsa-let-7g-5p | Prostatic neoplasms | MNDR-E-MI-02062 |
| MNDR | hsa-let-7g-5p | High grade dysplastic nodule | MNDR-E-MI-02063 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCC10 | Homo sapiens | RR00023406 |
TOP